Company Information & Drug Savings for Genzyme Corporation Medications
Genzyme, now part of Sanofi, pioneered treatments for rare genetic diseases. The company developed enzyme replacement therapies including Cerezyme for Gaucher disease, Fabrazyme for Fabry disease, and Lumizyme for Pompe disease. Genzyme also created Lemtrada for multiple sclerosis and Thyrogen for thyroid cancer follow-up. Sanofi’s rare disease division continues Genzyme’s mission of transforming lives of patients with orphan diseases.
How to Contact Genzyme Corporation
Phone
1-800-745-4447Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
